Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers.

Ainurofiq A, Rosalin EA, Istiyono MS, Maharani NA, Fauzy R, Sugiharti SN, Safa YF

Open source

DOI
10.34172/apb.46836
Published
2026 Jun
Container
Advanced pharmaceutical bulletin
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34172/apb.46836,
  title = {Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers.},
  author = {Ainurofiq A and Rosalin EA and Istiyono MS and Maharani NA and Fauzy R and Sugiharti SN and Safa YF},
  year = {2026},
  journal = {Advanced pharmaceutical bulletin},
  doi = {10.34172/apb.46836},
  url = {https://doi.org/10.34172/apb.46836}
}

RIS

TY  - JOUR
TI  - Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers.
AU  - Ainurofiq A
AU  - Rosalin EA
AU  - Istiyono MS
AU  - Maharani NA
AU  - Fauzy R
AU  - Sugiharti SN
AU  - Safa YF
PY  - 2026
JO  - Advanced pharmaceutical bulletin
DO  - 10.34172/apb.46836
UR  - https://doi.org/10.34172/apb.46836
ER  - 

APA

A, A., EA, R., MS, I., NA, M., R, F., SN, S., & YF, S. (2026). Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers.. Advanced pharmaceutical bulletin. https://doi.org/10.34172/apb.46836

Source records